Huakang Pharma: to terminate 30,000 t/a xylitol technology upgrading project

Summary: Huakang Pharma plans to terminate its 30,000 t/a xylitol technology upgrading project. The IPO proceeds originally used in the xylitol project will be invested in its 30,000 t/a D-xylose intelligent upgrading and transformation project. On 1...

Corn Products China News 202205

www.cnchemicals.com